IP Waiver Talks Hinge On Use Of Big Pharma's Trade Secrets
As advocates for a World Trade Organization proposal to temporarily waive intellectual property protections for COVID-19 vaccines try to win more support from developed countries, one obstacle to reaching consensus is...To view the full article, register now.
Already a subscriber? Click here to view full article